Two Sigma Advisers
AXDX

Two Sigma Advisers’s Accelerate Diagnostics AXDX Stock Holding History

Two Sigma Advisers’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,040
Closed -$49.7K – 2587
2022
Q4 		$49.7K Sell
7,040
-2,130
-23% -$23.3K ﹤0.01% 2362
2022
Q3 		$139K Buy
9,170
+440
+5% +$7.28K ﹤0.01% 2264
2022
Q2 		$87K Sell
8,730
-36,530
-81% -$323K ﹤0.01% 2404
2022
Q1 		$652K Buy
45,260
+8,800
+24% +$251K ﹤0.01% 1852
2021
Q4 		$1.9M Buy
36,460
+31,020
+570% +$1.73M ﹤0.01% 1227
2021
Q3 		$317K Sell
5,440
-4,780
-47% -$312K ﹤0.01% 2093
2021
Q2 		$824K Sell
10,220
-3,130
-23% -$249K ﹤0.01% 1719
2021
Q1 		$1.11M Buy
13,350
+1,190
+10% +$121K ﹤0.01% 1601
2020
Q4 		$922K Buy
12,160
+9,500
+357% +$851K ﹤0.01% 1602
2020
Q3 		$284K Sell
2,660
-7,390
-74% -$1.03M ﹤0.01% 2030
2020
Q2 		$1.52M Buy
10,050
+4,890
+95% +$482K ﹤0.01% 1359
2020
Q1 		$430K Buy
5,160
+3,530
+217% +$497K ﹤0.01% 1863
2019
Q4 		$275K Buy
+1,630
New +$269K ﹤0.01% 2091

Other funds holding AXDX

GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $214M AUM 45.87% 1-Year Est. Return

Two Sigma Advisers's AXDX Position: Q1 2023 in Review

Two Sigma Advisers sold out of Accelerate Diagnostics (AXDX) in Q1 2023, closing a stake of 7,040 shares — an estimated $49.7K sold.

Two Sigma Advisers first reported a position in AXDX in Q4 2019 and held it in 13 quarters. The position peaked at $1.9M in Q4 2021. 67 funds tracked by Wall St. Rank hold AXDX as of Q1 2023.

  • Two Sigma Advisers reported no remaining Accelerate Diagnostics position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 7,040 Accelerate Diagnostics shares in Q1 2023, an estimated $49.7K.
  • Two Sigma Advisers first reported a position in Accelerate Diagnostics in Q4 2019 and held it in 13 quarters.
  • Two Sigma Advisers's Accelerate Diagnostics position peaked at $1.9M in Q4 2021.
  • 67 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2023.

Based on Two Sigma Advisers's 13F filing for Q1 2023, filed 15 May 2023.